author-photo

Nicholas R Hoeh

University of Auckland

2

Papers

4

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A randomised, double-blind, active placebo-controlled, parallel groups, dose-response study of scopolamine hydrobromide (4-6 μg/kg) in patients with major depressive disorder.

2020 Trials
Show All
- Source
- Cite
- Save
Citations (1)
An open-label feasibility study of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression in the New Zealand healthcare context.

2019 The New Zealand Medical Journal
Show All
- Source
- Cite
- Save
Citations (3)